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A
 
BSTRACT
Background:
 
High-molecular size mite antigen
fraction (HM1) induced macrophage activation and
prolonged airway inflammation from mite-sensitized
mice. In the present study, we investigated the
inflammatory factors in the HM1-activated macro-
phage in both non-immunized splenocytes and
bronchoalveolar lavage (BAL) from mite-immunized
and HM1-exposed mice.
 
Methods:
 
Dermatophagoides farinae
 
 feces (Dff) extract
was divided into HM1 and HM1-depleted fraction (DH)
by size-exclusion chromatography. Transcriptional gene
induction of the pro-inflammatory cytokines tumor
necrosis factor (TNF)-
 
α
 
 and interleukin (IL)-12 and
cytokine-inducible nitric oxide synthase (iNOS) in splenic
macrophages stimulated with HM1 or DH was analyzed
by using semiquantitative reverse transcription–
polymerase chain reaction. Nitric oxide (NO) pro-
duction was measured by using diaminofluoresceins
(DAF), fluorescence indicators.
 
Results:
 
Gene expression of TNF-
 
α
 
, IL-12 p40 and
iNOS was observed with HM1 stimulation of splenic
macrophages from non-immunized mice. In addition,
the release of NO induced by HM1-stimulated splenic
macrophages increased in a dose-dependent manner.
However, splenic macrophages stimulated with DH
induced TNF-
 
α
 
 and IL-12 p40, but not iNOS, gene
expression. Similarly, significant iNOS mRNA expres-
sion was detected in alveolar macrophages recovered
from HM1-exposed mice, but not from DH-exposed
mice.
 
Conclusion:
 
In the present study, HM1 induced iNOS
mRNA expression and NO production both 
 
in vitro
 
and 
 
in vivo
 
. The present results suggest that the ability
of HM1 to induce NO production may be one of the
causes aggravating airway inflammation in HM1-
exposed mice.
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I
 
NTRODUCTION
 
The inflammatory response in asthma is associated with
airway hyperresponsiveness and the accumulation of
various cells, including eosinophils, mast cells and, most
importantly, CD4+ T helper (Th) 2 lymphocytes, which
can be isolated from the lungs of asthmatic patients.
 
1,2
 
In contrast, clinical studies have demonstrated that
the number of activated Th1 lymphocytes and macro-
phages, which usually suppress the ability of Th2 effector
cells 
 
in vitro
 
, was increased in bronchoalveolar lavage
fluid (BALF) from human asthmatic patients.
 
3
 
 Moreover,
recent studies have demonstrated that Th1 lymphocytes
are not protective, but lead to further problems in murine
models of asthma.
 
4,5
 
 The aggravation in asthma is
usually considered to proceed in association with various
cytokines, chemokines and enzymes that are released
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from the various types of cells that infiltrate into the
airway.
House dust mite, 
 
Dermatophagoides farinae
 
 (Df), is well
recognized as a major source of bronchial asthma. Pre-
viously, we demonstrated that HM1 fractionated from Df
feces extraction (Dff) by size-exclusion chromatography
induced a proliferative response of T cells from non-
immunized mice without major histocompatibility complex
(MHC) class II restriction via macrophage activation.
 
6
 
In Dff-immunized mice, but not in non-immunized
mice, HM1 developed and maintained airway hyper-
responsiveness at least 120 h after final inhalation.
The HM1-depleted fraction (DH)-exposed mice similarly
demonstrated aggravated airway hyperresponsiveness,
but the airway hyperresponsiveness in these mice was not
maintained. We also demonstrated that aggravation of
airway hyperresponsiveness was associated with the
accumulation of macrophages in the lung.
 
6
 
Clear evidence has been reported that alveolar
macrophages in the inflammation are associated with
allergic airway diseases such as asthma.
 
7
 
 Alveolar
macrophages have been identified as potent producers
of several cytokines. These include macrophage inflam-
matory protein-1
 
α
 
 and tumor necrosis factor (TNF)-
 
α
 
,
which possess pro-inflammatory properties.
 
8,9
 
 The
cytokines were involved in the production of NO, which
was upregulated in pulmonary inflammatory diseases.
 
10,11
 
In allergic patients
 
12
 
 and in animal models (rats
 
13
 
 and
guiniea pigs
 
14,15
 
) of asthma, allergen provocation resulted
in enhanced endogenous NO production during the late
asthmatic response.
To further investigate the HM1-induced association
between activated macrophages and enhancement of
airway hyperresponsiveness, we investigated HM1-induced
mRNA expression of the pro-inflammatory cytokine TNF-
 
α
 
and inducible NO synthase (iNOS). In the present study,
we proved that HM1 is a potent inducer of iNOS.
 
M
 
ETHODS
 
Mite antigens
 
Mite antigens were prepared according to previous
reports.
 
16,17
 
 Briefly, Df feces extracts from whole mite
culture (Dff) was applied to a Superdex 75 column
(Amersham Pharmacia Biothech, Uppsala, Sweden) and
eluted with 0.9% NaCl. The highest peak, over 70 kDa,
was collected as HM1. The content of HM1 in Dff was
estimated to be approximately 20%. The HM1 fractions
removed were dialyzed and lyophilized and used as the
HM1-depleted Dff fraction (DH). Finally, 2.4 g DH was
recovered from 3 g Dff.
 
Antigen exposure to Dff-immunized mice
 
Female BALB/c mice (6 weeks old) were sensitized twice
with Dff (50 
 
µ
 
g) adsorbed to 1 mg aluminum hydroxide
by intraperitonaeal injections at 5 day intervals. Then,
immunized mice were fixed and exposed to aerosols of
1% antigen (20 mL for 20 min) through their airways for
10 days.
 
Cell preparation
 
Splenic macrophages (CD11b+ cells) were prepared
from non-immunized murine splenocytes using Magnetic
Cell Sorting (MACS; Bergisch, Gladbach, Germany),
according to previous reports.
 
18
 
 Splenic macrophages
were purified up to 98%.
Alveolar macrophages were isolated from the
bronchoalveolar lavage (BAL) of Dff-immunized mice
receiving daily exposure to aerosolized HM1, DH or
phosphate-buffered saline (PBS) for 10 days. Broncho-
alveolar lavage fluid was collected from four separate
1 mL PBS washes of the lungs. Approximately 3.6 mL of
the total fluid was recovered and centrifuged (700 
 
g
 
 for
10 min at 4
 
°
 
C). Alveolar macrophages were purified up
to 97% by MACS.
 
Cell culture
 
Splenic macrophages (1 
 
×
 
 10
 
6
 
 cells/mL) were cultured
with 10 
 
µ
 
g/mL HM1 in RPMI 1640 medium (Sigma
Chemical, St Louis, MO, USA) containing 10% heat-
inactivated fetal calf serum (Sigma) and 0.05 mmol/L
2-merchaptoethanol in a flat-bottomed microtiter culture
plate at 37
 
°
 
C for 2–24 h under 5% CO
 
2
 
.
 
RNA isolation and reverse 
transcription–polymerase chain reaction
 
Total RNA was extracted from splenic macrophages
cultured with respective mite antigens and alveolar
macrophages from BAL of corresponding mite antigen-
exposed mice. The method used was the Trizol method
 
19
 
and the mRNA was transcribed using 0.5 
 
µ
 
g Oligo (dT)
primer (Gibco BRL, Grand Island, NY, USA) and 200 U
SUPERSCRIPT™II (Gibco BRL) reverse transecriptase in a
final volume of 20 
 
µ
 
L. Polymerase chain reaction (PCR)
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was performed on a GeneAmp PCR System 9600
(Perkin Elmer, Norwalk, CT, USA) in a reaction contain-
ing dNTP mix (20 pmol; Takara, Kyoto, Japan), forward
and reverse primer (20 pmol each), 
 
×
 
10 EX Taq buffer
(2 
 
µ
 
L), optimum cDNA concentration and 0.5 U Taq
polymerase, which was made up to 20 
 
µ
 
L with distilled
water. The PCR conditions were as follows: prede-
naturation at 94
 
°
 
C for 4 min, followed by 30–38 cycles
of denaturation at 94
 
°
 
C for 30 s, optimal annealing
temperature for 30 s and elongation at 72
 
°
 
C for 60 s.
The amplimer sequences and lengths of the expected
PCR products are given in Table 1.
 
Determination of NO from splenic 
macrophages stimulated with HM1 and DH
 
Splenic macrophages were cultured with several con-
centrations of HM1 or DH for 22 h and cells were
then washed twice with PBS. Cells were incubated with
1 mmol/L DAF-2 and 100 mmol/L 
 
L
 
-arginine for 6 h.
The supernatants were transferred to 96-well micro-
plates and the fluorescence was measured with a
fluorescence microplate reader calibrated for excitation
at 485 nm and emission at 538 nm.
 
20
 
 The level of NO
production was expressed as concentrations of the
DAF-2T fluorescent compound, which was used for the
fluorescent detection of NO using DAF-2.
 
R
 
ESULTS
 
HM1 induces iNOS gene expression
 
First, splenic macrophages from non-immunized mice
were cultured with HM1 or DH, and the mRNA expression
of MHC class II, functional activation markers TNF-
 
α
 
and IL-12 p40, pro-inflammatory cytokines and iNOS
was analyzed by reverse transcription (RT)–PCR. To
obtain comparable data on steady state levels of mRNA
in the different samples, cDNA levels were normalized
using GAPDH housekeeping gene expression levels. The
PCR analyses were performed using equal amounts of
cDNA with a non-saturating number of amplification
cycles. Similar expression levels of mRNA encoding MHC
class II, TNF-
 
α
 
 and IL-12 p40 were observed in splenic
macrophages cultured with either HM1 or DH. Splenic
macrophages cultured with HM1 promoted efficient
induction of iNOS mRNA in the presence or absence of
polymixn B (10 
 
µ
 
g/mL). However, the DH stimulus could
not induce mRNA coding for iNOS (Fig. 1).
 
Release of NO from splenic macrophages 
cultured with HM1
 
The supernatant of macrophages cultured with HM1
produced fluorescent products upon incubation with
DAF-2. The amount of the products that represented
NO production was positively correlated with the con-
centration of HM1. We also found that the release of
NO could not be detected in supernatants from macro-
phages cultured with DH (Fig. 2).
 
HM1 inhalation-induced iNOS expression of 
alveolar macrophages
 
 in vivo
 
Our previous report indicated that airway hyper-
responsiveness was maintained in HM1-exposed mice
for at least 120 h after final antigen inhalation by
 
Table 1
 
List of mRNA of interest, expected size of amplified cDNA and sequence of nucleotide primers
mRNA of interest and size of expected amplified cDNA Primer sequences (sense and antisense 5
 
′
 
–3
 
′
 
)
GAPDH (306 bp) CGGAGTCAACGGATTTGGTCGTAT
AGCCTTCTCCATGGTGGTGAAGAC
MHC class II (229 bp) TATGTGGACTTGGATAAGAAG
ACAAAGCAGATAAGGGTGTTG
IL-12 p40 (384 bp) CTGGCCAGTACACCTGCCAC
GTGCTTCCAACGCCAGTTCA
TNF-
 
α
 
 (692 bp) ATGAGCACAGAAAGCATGATCCGC
CCAAAGTAGACCTGCCCGGACTC
iNOS (481 bp) AGCTCCTCCCAGGACCACAC
ACGCTGAGTACCTCATTGGC
 
MHC, major histocompatibility complex; IL-12, interleukin-12; TNF-
 
α
 
, tumor necrosis factor-
 
α;
 
 iNOS, inducible nitric oxide synthase.
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Dff-immunized mice, although that of DH-exposed mice
was reverted to normal levels.18 To investigate the
expression of mRNA for iNOS from alveolar macro-
phages under these conditions, BALF was collected at
120 h after final antigen exposure from Dff-immunized
mice. The alveolar macrophages in the BALF were
recovered. The cell numbers of alveolar macrophages
were 3.3 ± 1.0, 11.9 ± 0.9 and 4.3 ± 2.3 ( × 103 cells/mL
BALF) for PBS-, HM1- and DH-exposed mice, respec-
tively. The mRNA expression for MHC class II, TNF-α,
IL-12 p40 and iNOS was analyzed by RT-PCR. The
expression of iNOS mRNA was detected in alveolar
macrophages from HM1-exposed, but not DH-exposed,
mice. The MHC class II, TNF-α and IL-12 p40 mRNA
was detected in both HM1- and DH-exposed mice
(Fig. 3).
DISCUSSION
The main findings of the present in vitro and in vivo
studies are that HM1 is a potent inducer of iNOS gene
expression from splenic/alveolar macrophages. We
demonstrated previously that HM1 exposure of Dff-
immunized mice resulted in the development of airway
hyperresponsiveness 24 h after inhalation and that the
hyperresponsiveness was sustained even 120 h after
inhalation. Although airway hyperresponsiveness was
observed in DH-exposed mice, it returned to control
levels as seen in mice that inhaled PBS mice within
120 h after final inhalation. It was found that HM1 was
able to enhance and prolong airway hyperresponsive-
ness compared with DH. In addition, there were still
significant amounts of alveolar macrophages accumulated
Fig. 1 High-molecular size mite antigen fraction (HM1)
stimulus-induced inducible nitric oxide synthase (iNOS) mRNA
expression from non-immunized murine macrophages. Splenic
macrophages (2.0 ×
 
 105 cells/well) derived from non-immunized
mice were cultured with 10 µ
 
g/mL mite antigen. Total RNA
preparations were isolated after 24 or 2 h incubation for iNOS
mRNA analysis or the analysis of other mRNA, respectively, and
analyzed by reverse transcription–polymerase chain reaction.
The polymerase chain reaction products were subjected to
agarose gel electrophoresis. IL-12, interleukin-12; TNF-α
 
, tumor
necrosis factor-α
 
; MHC, major histocompatibility complex; PBS,
phosphate-buffered saline; DH, HM1-depleted fraction.
Fig. 2 Production of nitric oxide (NO) by macrophages
stimulated with high-molecular size mite antigen fraction
(HM1; ) and the HM1-depleted fraction (DH; ). Splenic
macrophages were cultured with mite antigen for 22 h and
washed with phosphate-buffered saline (PBS) and resuspended
in PBS containing 1 µmol/L DAF-2 and 100 µmol/L L-arginine.
After 6 h incubation, the fluorescence was measured with a
fluorescence microplate reader calibrated for excitation at
485 nm and emission at 538 nm. The level of NO production is
expressed as the concentration of the DAF-2T fluorescent com-
pound used for the fluorescent detection of NO using DAF-2.
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in HM1-exposed murine lung 120 h after inhalation. In the
present study, we focused on the effects of HM1 on
macrophage activation and examined pro-inflammatory
cytokine gene expression from macrophages stimulated
with HM1.
Incubation of splenic macrophages from non-
immunized mice for 24 h with HM1 indicated significant
iNOS gene expression and NO production. However,
no expression of the iNOS gene was observed follow-
ing DH stimulation, although the treatment induced
TNF-α and IL-12 p40 gene expression. Nitric oxide
production and iNOS gene expression are known to
be generated following stimulation with lipopoly-
saccharide (LPS), platelet-activating factor and immune
complexes. Our results demonstrate that HM1 directly
elicits iNOS mRNA expression and NO production,
implying that the expression of iNOS mRNA was the
result of the activation of a different pathway from that
activated by immune complexes that interact with FcγR on
the surface of macrophages. We also demonstrated that
iNOS gene expression induced by HM1 was not affected
by polymyxin B, a cyclic cationic peptide antibiotic that
neutralizes the biological activity of LPS.
The concentration of NO in exhaled air is increased in
asthmatic patients and experimental animals.21 The high
levels of NO could have detrimental effects by causing
epithelial damage and airway hyperreactivity.22,23 These
observations suggest strong correlations between NO
production in the lung and allergic asthma.
Airway inflammation was developed by IL-5-
producing Th2 cells following eosinophil infiltration and
was abrogated by interferon (IFN)-γ-producing Th1 cells
and soluble IL-4 receptor.24,25 In fact, Th1 cells and
alveolar macrophages identified in the BALF of asthmatic
patients were more active than those from healthy
subjects.26–28 The Th1-type T cell mainly mediates cellular
immune responses and induces delayed-type hyper-
sensitivity in humans and murine lung tissue.29 These
results explain the complexity of allergic asthma and
indicate the difficulty of treating asthma. Recent studies
using animal models of asthma have indicated that iNOS
inhibitors block the infiltration of inflammatory cells in
antigen-exposed mouse lung.30 These studies also
indicate that iNOS-deficient mice do not show allergic
airway inflammation induced by allergen exposure.31 In
addition, inhalation of an iNOS inhibitor by asthmatic
patients inhibited NO production in the airway.32 These
facts support the feasibility of an NO-targeting agent as a
novel approach for the treatment of asthma.
The mRNA expression of IL-12 p40 and TNF-α
seemed to decrease in DH-exposed mice compared with
HM1-exposed mice. However, the mRNA expression of
both IL-12 p40 and TNF-α was measured semiquantita-
tively. Therefore, accurate expression of the mRNA of
both IL-12 p40 and TNF-α needs to be determined. In
the future, we must measure mRNA expression of both
IL-12 p40 and TNF-α quantitatively to determine the
relationship between NO production and the expression
of these cytokines.
In the present study, we demonstrated that HM1
directly induced iNOS gene expression and NO pro-
duction both in vitro and in vivo in alveolar macrophages.
In conclusion, we demonstrated the ability of HM1 to
Fig. 3 Inducible nitric oxide synthase (iNOS) mRNA gene
expression in alveolar macrophages from high-molecular size
mite antigen fraction (HM1)-exposed mice. The BALB/c mice
were immunized twice with 50 µg Dermatophagoides farinae
feces at 5 day intervals and then exposed daily to HM1, the
HM1-depleted fraction (DH) or phosphate-buffered saline (PBS)
for 10 days. At 120 h after the final exposure, alveolar macro-
phages were collected and mRNA was analyzed for major
histocompatibility complex (MHC) class II, tumor necrosis
factor (TNF)-α, interleukin (IL)-12 p40 and iNOS by reverse
transcription–polymerase chain reaction. The mRNA levels of
each sample were normalized against GAPDH expression
levels. Polymerase chain reaction products were analyzed by
agarose gel electrophoresis.
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induce NO production by analyzing iNOS gene expres-
sion and measuring the release of NO. Generally, it is
well known that immune complexes induce iNOS gene
expression and NO production from macrophages.
High-molecular size mite antigen fraction is a candidate
for the production of NO to aggravate airway hyper-
responsiveness in mite-allergic asthma.
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